Becker's Clinical Quality & Infection Control

July 2016 Issue of Becker's Infection Control & Clinical Quality

Issue link: https://beckershealthcare.uberflip.com/i/704703

Contents of this Issue

Navigation

Page 37 of 47

904 Caribbean Drive | Sunnyvale, CA 94089 USA | TOLL FREE +1.888.336.2743 | PHONE +1.408.541.4191 | FAX +1.408.541.4192 Don't ignore the facts. Rapid and accurate detection of toxigenic C. diffi cile with Xpert ® C. diffi cile/Epi can help stop the spread of deadly infections. For in vitro diagnostic use REFERENCES 1 Lessa FC, et al. N Engl J Med. 2015;372:2369-70. 2 Cohen SH, et al. Infect Control Hosp Epidemiol. 2010;31:431-55. 3 Surawicz CM, et al. Am J Gastroenterol. 2013;108:478-98. 4 Dallal RM, et al. Ann Surg. 2002;235:363-72. 5 Curry SR, et al. Clin Infect Dis. 2013;57:1094-102. 6 Tschudin-Sutter S, et al. Infect Control Hosp Epidemiol. 2015;36:1324-9 A quick check of the facts: • C. dif cile infections(CDI) are associated with signi cant morbidity and mortality worldwide. In the US alone, 29,000 people die each year from CDI. 1 • Toxin testing fails to detect some patients with symptomatic and even life-threatening C. dif cile infections 2-4 • Patients colonized with toxigenic C. dif cile can spread infection to others and are at increased risk of developing symptomatic infections 5,6 Get real answers www.cepheid.com

Articles in this issue

Links on this page

view archives of Becker's Clinical Quality & Infection Control - July 2016 Issue of Becker's Infection Control & Clinical Quality